Background:
The main risk factors for atherosclerosis patients are not fully explicated. The aim of this study was to analyze the levels of blood lipid and glycosylated lipoprotein in patients with coronary artery atherosclerosis and healthy individuals and to study the relationship between the glycosylated lipoprotein and atherosclerosis.
Methods:
The study involved 200 patients diagnosed with myocardial infarction caused by coronary atherosclerosis as case group and 230 healthy individuals as control group. We analyzed and contrasted the levels of blood lipid and glycosylated lipoprotein between the different groups. In addition, we investigated the correlation between glycosylated low-density lipoprotein (G-LDL) and glucose levels.
Results:
There is no statistical difference between the level of TG in case group and control group. The level of CHOL, HDL-C, and LDL-C in case group is significantly lower than that in control group (3. and HbA1c (r = 0.625, 0.706, P < 0.05), and there was no relevance with LDL-C (r = 0.331, P > 0.05).
Conclusion:
Hyperlipidemia is not an important cause of coronary atherosclerosis.
High glucose levels and glycosylated lipoprotein are of high importance in the development and progression of coronary atherosclerosis.
K E Y W O R D S
coronary atherosclerosis, glycosylated lipoprotein, myocardial infarction It is well-established that diabetes mellitus is an independent risk factor for atherosclerosis. 7 Several studies have demonstrated that patients with high glucose are at higher risk for atherosclerosis comparison to people with normal glucose. 8, 9 The 2015 U.S. Residents'
Dietary Guidelines removed restrictions on residents' cholesterol intake. The Dietary Guidelines Advisory Committee (DGAC) is considered that the intake of cholesterol in the human body does not need to be taken into account, and it is recommended to control the intake of sugar. 10 Therefore, we tested the hypothesis that high glucose might increase glycosylated lipoprotein levels and promotes atherosclerosis.
The aim of this study was to investigate the clinical characteristics and the levels of lipid, glucose, and glycosylated lipoprotein of AMI patients in newly diagnosed atherosclerosis compared with control individuals.
| MATERIAL S AND ME THODS

| Subjects
Between At the same time, we enrolled 230 healthy people as control individuals. Inclusion criteria: People have no coronary heart disease, chronic obstructive pulmonary disease, peripheral vascular disease, and severe liver and kidney disease history.
Electrocardiogram and echocardiography showed cardiac function is normal.
| Laboratory measurements
We collected 5 mL of venous blood samples from participants after an overnight fast and centrifuged at 1600 g/min for 15 min.
The samples were taken for measurement. Glycosylated hemoglobin (HbA1c) was measured by high-performance liquid chromatography (Tosoh, Tokyo, Japan). Fast plasma glucose (FPG), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were measured by hexokinase method (cobas 8000; ROCHE, Germany). Collection of samples and analysis were according to laboratory standard operating procedure and had CAP accreditation.
| Glycosylated lipoprotein measurement
All serum was stored at −20°C for glycosylated lipoprotein measurement. Glycosylated high-density lipoprotein (G-HDL) and glycosylated low-density lipoprotein cholesterol (G-LDL) were measured by ELISA (Human Gly-HDL/LDL ELISA Kit, bioTSZ, USA). 
| Statistical analyses
| RE SULT
| Characteristics of study subjects
Among the 430 study subjects, 200 (46.5%) were AMI patients and 230 (53.5%) were control individuals. The clinical characteristics of them are presented in Table 1 . Both AMI patients and control individuals had an equal sex and age distribution, whereas the AMI group had a strong predominance of hypertension and diabetes. The AMI patients had significantly higher heart rate, SBP, and DBP than control individuals (P < 0.001).
| Comparison of lipid and glucose levels between the subjects with and without coronary atherosclerosis
The clinical and laboratory characteristics of the studied subjects with and without coronary atherosclerosis are shown in Table 2 . Both the case group and control group had an equal sex and age distribution. The levels of FPG and HbA1c in AMI patients were higher than in control individuals (P < 0.001).
Interestingly, there is no statistical difference between the level of TG in case group and control group. And the level of CHOL, LDL-C in patients with coronary atherosclerosis is lower than in control individuals.
| The levels of glycosylated lipoprotein in study subjects
The (Figure 1 ).
| Analyses of G-LDL correlation with lipid and glucose in the coronary atherosclerosis group
The Spearman correlation analyses for G-LDL are shown in Table 3 .
The level of G-LDL is correlated with FPG and HbA1c levels (P < 0.05). To the contrary, G-LDL level is independent of the level of LDL-C (P > 0.05).
| D ISCUSS I ON
Atherosclerosis is a type of chronic progressive pathological process which lipids and blood components deposited in the arterial intima, smooth muscle cells and collagen fibrosis hypertrophied, necrosis and calcification and other degrees of lesions are involved. 12 AMI caused by coronary atherosclerosis has a high rate of recurrence, disability, and mortality, which seriously threatens the physical and mental health of middle-aged and elderly patients. 3 The mechanism of AS is not fully established. The traditional view is that hyperlipidemia, especially high LDL, is a major risk factor for the development of atherosclerosis. 13 However, some studies showed that blood lipid levels are not significantly related to atherosclerosis. 14 At present, most studies focused on the role of modified lipoprotein especially oxidized lipoprotein in atherosclerosis. 15, 16 But investigations about the glucose and glycosylated lipoprotein in atherosclerosis were scarce. Therefore, we carried out this study to access the characteristics of AMI patients with atherosclerosis and tried to explore the risk factors in the development of atherosclerosis.
In this study, AMI patients and control individuals showed no significant differences in the level of TG. The level of CHOL and LDL-C in patients is lower than in control individuals. However, the level of FPG, HbA1c, and glycosylated lipoprotein is significantly higher in AMI patients than in control individuals. These findings are interesting and suggested that we need to fully recognize glucose level was important in the development of atherosclerosis. It is noteworthy that the G-LDL level only has associated with FPG and HbA1c, but independent of LDL. So glucose control is very important while lowering lipids. There were some limitations in our study, such as missing biochemical indexes, and missing information of diet and exercise. The included patients were hospitalized patients, and there might be selection bias in the study. Next, we need prospective studies to evaluate the role of glycosylated lipoprotein in the assessment and prevention of atherosclerosis. 
| CON CLUS ION
